← Open Payments lookup

HARISH GOYAL: Open Payments

NPI 1558517391 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$970 in 40 payments from 13 companies in 2025. Trend: 2023 $564 · 2024 $986 · 2025 $970

Food & beverage: $970
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.8$181
Janssen Pharmaceuticals, Inc3$159
Axsome Therapeutics, Inc.6$123
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$96
Lundbeck LLC3$87
E.R. Squibb & Sons, L.L.C.3$67
Otsuka America Pharmaceutical, Inc.3$61
Takeda Pharmaceuticals U.S.A., Inc.3$52
Bausch Health US, LLC3$51
Corium, LLC1$31

Products named: Qelbree, SPRAVATO, REXULTI, Auvelity, CAPLYTA, COBENFY, TRINTELLIX, APLENZIN.

Industry payments across VA — which companies pay providers there.